Stonepine Capital Management’s Interpace Biosciences, Inc. Common Stock IDXG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-284,730
| Closed | -$880K | – | 24 |
|
|
2020
Q3 | $880K | Buy |
+284,730
| New | +$880K | 0.92% | 16 |
|
|
2020
Q2 | – | Sell |
-178,295
| Closed | -$924K | – | 28 |
|
|
2020
Q1 | $924K | Buy |
178,295
+83,910
| +89% | +$435K | 0.98% | 24 |
|
|
2019
Q4 | $472K | Sell |
94,385
-21,653
| -19% | -$108K | 0.33% | 21 |
|
|
2019
Q3 | $922K | Sell |
116,038
-59,280
| -34% | -$471K | 0.89% | 19 |
|
|
2019
Q2 | $1.27M | Buy |
175,318
+31,915
| +22% | +$231K | 0.88% | 21 |
|
|
2019
Q1 | $1.15M | Buy |
+143,403
| New | +$1.15M | 0.66% | 26 |
|